Brief: Pediapharm receives FDA supplement approval regarding Naproxen suspension

Medexus Pharmaceuticals

11/05/2016 13:30

May 11 (Reuters) - Pediapharm Inc  PDP.V  : 
    * Approval triggered second and final payment of us$2 
million in cash 
    * Pediapharm receives fda supplement approval regarding 
naproxen suspension in the us, receives additional us$2 million 
from atnahs pharma 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nCCN3Kbp5X 
Further company coverage:  PDP.V  
 
 (Bengaluru Newsroom: +1-646-223-8780)